Perioperative Topical Nepafenac After Epiretinal Membrane Surgery

NCT07736690 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Epiretinal Membrane
Macular Pucker

Interventions

DRUG: Nepafenac 0.1% Ophthalmic Suspension
PROCEDURE: Pars Plana Vitrectomy With Epiretinal Membrane and Internal Limiting Membrane Peeling

Sponsor

Ankara Yildirim Beyazıt University